Commitments and Contingencies - Narrative (Details)			12 Months Ended
	Jun. 30, 2022 USD ($)	Jan. 01, 2021 USD ($) shares	Dec. 31, 2023 USD ($) term	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Other Commitments [Line Items]
Operating lease cost			$ 5,874,000	$ 1,158,000	$ 264,000
Operating cash flows paid for operating leases			$ 4,854,000	780,000
Number of additional periods | term			2
Annual commitments			$ 39,780,000
Research and development			373,281,000	437,072,000	181,486,000
Moda Pharmaceuticals LLC
Other Commitments [Line Items]
Research and development			$ 0	$ 0	$ 0
Moda Pharmaceuticals LLC | Moda Agreement
Other Commitments [Line Items]
Eligible development milestone payments		$ 81,612,000
Eligible commercial milestone payments		$ 30,171,000
Initial term of agreement (in years)		4 years
Moda Pharmaceuticals LLC | License agreement | Moda Agreement
Other Commitments [Line Items]
Payment for license agreement		$ 2,700,000
Issuance of common shares as payment for assets (in shares) | shares		37,836
Issuance of common shares as payment for assets		$ 3,243,000
West Palm Beach Lease Agreement
Other Commitments [Line Items]
Lease agreement, term	120 months
Option to extend, term	60 months
Minimum
Other Commitments [Line Items]
Lease agreement, term			1 year
Option to extend, term			5 years
Minimum | West Palm Beach Lease Agreement
Other Commitments [Line Items]
Annual commitments	$ 1,263,000
Maximum
Other Commitments [Line Items]
Lease agreement, term			10 years
Option to extend, term			10 years
Maximum | West Palm Beach Lease Agreement
Other Commitments [Line Items]
Annual commitments	$ 1,649,000
Research and Development Arrangement
Other Commitments [Line Items]
Research commitments			$ 9,025,000
Research commitment period			1 year